✅ 58% Greater FMD Improvement vs. placebo(p<0.001)
✅ 24-hr ABPM Reduction: -11.2/-6.5 mmHgsystolic/diastolic (p<0.01)
✅ Plasma ADMA Reduction: 34% decreasecorrelating with NO restoration
For nutraceutical manufacturers, thisvalidates strategic amino acid ratios for vascular rejuvenation products. BlueEyes Biotech supplies pharmaceutical-grade nitric oxide precursors:
- Ultra-Pure L-Citrulline DL-Malate (2:1ratio, >99.5% HPLC)
- Sustained-Release L-Arginine AKG (85%purity, GRAS Notice No. 000128)
- Synergistic Complexes:Citrulline/Arginine + Pomegranate Ellagitannins
Procurement Advantages:
•Dose-OptimizedProfiles: Clinically effective 6g Citrulline + 3g Arginine daily
•PatentedDelivery Tech: LysoPrime® for 3x enhanced intestinal absorption
•StabilitySolutions: Nitrogen-flushed packaging preventing oxidation
Regulatory-Ready Documentation:
- Full RCT Dataset available for brandsubstantiation
- Heavy Metal Control (ICH Q3D, ≤0.05ppm cadmium)
- TSE/BSE-Free Certification for globalcompliance
Multi-Industry Applications:
➤Cardiovascular Supplements: Endothelialrepair formulas for metabolic health
➤Men's Vitality Products: Naturalerectile function support
➤Sports Nutrition: Blood flow amplifiersfor performance recovery
➤Pharmaceutical Intermediates: API forhypertension/ED drug development
Critical Safety Advantage:
▶️ Zero TMAO Production Risk vs.choline-based alternatives
▶️ Renal/Liver Safety Profiles confirmedin sub-studies
Request Clinical Trial Protocol & COA: